Mevion Medical to expand into China
Mevion Medical Systems of Littleton is set to receive up to $200 million in financing as part of a joint venture in China.
The radiation therapy company announced Tuesday that it will form a joint venture in the world’s most populous nation to produce, sell and service proton therapy systems for the Chinese market. The partnership with HOPU Investments, YuanMing Capital, other Chinese investors, as well as existing investors, will also net the company up to $200 million in the investment agreement.
“Proton therapy is an increasingly significant treatment modality for cancer centers around the world, and we see real value in advancing accessibility to this important therapy in China and elsewhere,” Sunny Li, senior managing director and head of technology investments of HOPU Investments, said in a statement.
The financing will help accelerate Mevion’s global expansion plans, according to the company.
WBJ Web Partners
Most Recent
Most Recent
0 Comments